Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Gene Polymorphism
85%
Methylation
75%
Blood Lead Level
46%
Folic Acid Blood Level
36%
Cyanocobalamin
36%
Selenium Blood Level
35%
Single-Nucleotide Polymorphism
30%
Binding Domain
29%
Eicosanoid Receptor
29%
DNA Methylation
29%
Vitamin Blood Level
28%
Haplotype
26%
Allele
25%
X Ray
25%
Case-Control Study
20%
Bone Density
19%
XRCC1
19%
Adiponectin
19%
Alternative Splicing
19%
High-Performance Liquid Chromatography
17%
Prevalence
15%
Autoantibodies
15%
Cross Sectional Study
14%
Adipogenesis
14%
Restriction Fragment Length Polymorphism
14%
Polymerase Chain Reaction
14%
Genetic Polymorphism
13%
Isoform
12%
Dose Response
12%
Atomic Absorption Spectroscopy
12%
MicroRNA
12%
Passive Smoking
12%
Phytochemical
12%
Folic Acid
12%
Alpha Oxidation
11%
B Cell
11%
Body Mass
11%
Glomerulus Filtration
11%
Methyltransferase
10%
Genetic Divergence
10%
Adipocyte
10%
Deoxycytidine
10%
Screening
9%
Clinical Trial
9%
Aldosterone Synthase
9%
Tumor Necrosis Factor Alpha
9%
DNA Methyltransferase
9%
Vascular Endothelial Growth Factor A
9%
Interleukin 8
9%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
58%
Chronic Kidney Failure
58%
Renal Cell Carcinoma
48%
Developmental Delay
48%
Vitamin B12
33%
Folic Acid
33%
Bladder Cancer
31%
Receptor Protein
29%
Synapsin II
29%
Randomized Controlled Trial
29%
Malignant Neoplasm
23%
Neoplasm
21%
Methyltransferase
20%
Case-Control Study
20%
Interleukin 8
19%
8 Hydroxydeoxyguanosine
19%
Fragility Fracture
19%
Tumor Necrosis Factor
16%
Disease
16%
High Performance Liquid Chromatography
16%
Carcinogenesis
14%
Cohort Study
14%
Prevalence
12%
Recurrent Disease
12%
Retrospective Study
11%
Colorectal Cancer
11%
DNA Glycosyltransferase
9%
DNA (Cytosine 5) Methyltransferase 1
9%
Tissue Inhibitor of Metalloproteinase 3
9%
Clinical Trial
9%
Carcinogenicity
9%
Uterine Cervix Cancer
9%
Nonalcoholic Fatty Liver
9%
Vasculotropin A
9%
Lesinurad
9%
Sjoegren Syndrome
9%
Feces microflora
9%
Musculoskeletal Disease
9%
Sarcopenia
9%
Mouth Carcinoma
9%
8 Hydroxyguanine
9%
Maleic Acid
9%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
9%
Sleep Disordered Breathing
9%
Progression Free Survival
9%
Cross-Sectional Study
9%
Atrial Fibrillation
9%
Zoledronic Acid
9%
Postherpetic Neuralgia
9%
Hyperuricemia
9%
Medicine and Dentistry
Urinary System
58%
Methylation
58%
Clear Cell Renal Cell Carcinoma
38%
Transitional Cell Carcinoma
29%
Medicine
29%
Odds Ratio
24%
Family Practice
23%
Metabolic Syndrome
22%
Receptor Protein
19%
Sarcopenia
19%
Synapsin II
19%
4 Iodo 2,5 Dimethoxyamphetamine
19%
Chronic Kidney Disease
19%
Hepatocellular Carcinoma
19%
8 Hydroxydeoxyguanosine
19%
Radiation Therapy
15%
Erythrocyte
12%
Bladder Cancer
12%
Sleep Quality
11%
Systematic Review
11%
Glomerular Filtration Rate
11%
Dual-Energy X-Ray Absorptiometry
11%
Middle Cerebral Artery
10%
Methyltransferase
10%
Study Subject
10%
Cardiovascular Disease
10%
Alcohol Consumption
10%
Skeletal Muscle
10%
Retrospective Study
10%
Arginine
10%
Prevalence
9%
Screening
9%
Geriatrics
9%
Nocturia
9%
Tubular Adenoma
9%
Cerebral Autoregulation
9%
Clinical Trial
9%
Internal Carotid Artery
9%
Carcinogenicity
9%
Transcatheter Arterial Chemoembolization
9%
Serum Albumin
9%
Hypoglycemia
9%
Brain Ischemia
9%
Meta-Analysis
9%
Insulin Resistance
9%
Repolarization
9%
Hypovitaminosis D
9%
Mouth Carcinoma
9%
Adolescent
9%
8-Oxoguanine
9%